"Over the years, I felt like I'd tried everything for weight loss; however, nothing worked for me long-term." Fed up and ...
By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers ...
Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental ...
Merck & Co. Inc. (NYSE: MRK) is rewarding its shareholders once again with a quarterly dividend of $0.81 per share, payable ...
Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...